BAZ2A and hepatocellular carcinoma: Li et al. [170] demonstrated that upregulation of BAZ2A promoted the growth of HCC cells in an anchorage-independent growth assay (frequently used to analyze the stem cell-like properties of tumors) by inducing the Wnt/β-catenin signaling pathway.